4 ms·
> About 6 percent of people who took metformin later developed long COVID-19, as determined by a medical diagnosis. In the placebo group, 10.6 percent of partic
by prirun 4y ago
> About 6 percent of people who took metformin later developed long COVID-19, as determined by a medical diagnosis. In the placebo group, 10.6 percent of participants developed long COVID-19.
> This meant that overall people who took metformin were 42 percent less likely to develop long COVID-19 compared to people who got the placebo.
I guess I am dumb, but it seems to me that people who took metformin were 4.6% less likely to develop long covid, not 42%, right?
- cpncrunch 4y agoNo, the 42% is correct. You have to compare the proportion who got longcovid taking the drug, vs those who got longcovid without taking it, i.e. (10.6-6)/10.6. Also, the study just looked at obese patients, who are at high risk of both diabetes and covid complications. So this likely just reduced those complications, and not "longcovid" as a whole (which can mean a number of different things). I would imagine it had no effect against the ME/CFS type of longcovid.